A Clinical Scoring System for Prediction of an Abnormal DMSA in Paediatric Patients After the First Episode of Febrile Urinary Tract Infection | Synapse
March 23, 2026
A Clinical Scoring System for Prediction of an Abnormal DMSA in Paediatric Patients After the First Episode of Febrile Urinary Tract Infection
Key Points
The aim is to evaluate the effectiveness of clinical biomarkers in predicting abnormal DMSA scans following a febrile urinary tract infection in children.
Assessment of serum creatinine, procalcitonin, and CRP levels in pediatric patients
Identification of patients with first episodes of febrile urinary tract infection
Correlational analysis between biomarkers and results of late DMSA scans
Higher serum creatinine and procalcitonin levels correlate with an increased risk of abnormal DMSA scans
CRP levels show potential utility in risk identification
Overall, the scoring system may aid in clinical decision-making for management after febrile UTI
Abstract
Serum creatinine, procalcitonin and CRP may be useful in identifying paediatric patients with first febrile UTI at risk of an abnormal late DMSA scan.